- World rank, all time
- #31,957 of 42,892
- Rank in Canada
- #689 of 896
- Research works
- 126 ▼ 12% vs 2013–17
- Citations
- 2.5k 20.0 per fractional work
- Top-10% rate
- 9.1% record average 16.5%
- Open access
- 30% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.5×
- Biochemistry, Genetics and Molecular Biology 3.6×
- Medicine 3.0×
- Chemistry 2.8×
- Nursing 2.5×
- Chemical Engineering 2.2×
- Immunology and Microbiology 1.5×
- Health Professions 1.2×
- Neuroscience 0.8×
- Decision Sciences 0.5×
- Agricultural and Biological Sciences 0.5×
- Mathematics 0.4×
- Physics and Astronomy 0.2×
- Engineering 0.2×
- Computer Science 0.2×
- Materials Science 0.1×
- Psychology 0.1×
Which keywords describe research at Micropharma (Canada)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Echocardiography, Cancer Treatment, Cell Proliferation, Immunotherapy, Heart Failure, Immune Response, Treatment Guidelines and Cancer.
- Transcriptional Regulation
- MAP Kinase
- Chamber Quantification
- Arginine Methylation
- Metastatic Breast Cancer
- tumor
- Tumor Microenvironment
- Radiopharmaceuticals
- Tumor Regression
- Gene Therapy
- Bisphosphonates
- Imaging
- Prostate Cancer
- Chronic Kidney Disease
- Treatment Guidelines
- PET Imaging
- Breast Cancer
- Immune Response
- Cell Proliferation
- Cancer Treatment
- Echocardiography
- Cancer
- Heart Failure
- Immunotherapy
- Obesity
- Pulmonary Hypertension
- Cancer Therapy
- Endothelial Dysfunction
- Right Heart Assessment
- Myocardial Infarction
- Dosimetry
- Osteonecrosis of the Jaw
- PET/CT
- Targeted Therapy
- Tumor Suppression
- Biomarkers
- Angiogenesis
- BRAF gene
- Diastolic Function
- Protein Arginine Methyltransferases
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Echocardiography3▲ 31×2 topics
- Cancer Treatment2▲ 34×2 topics
- Cancer2▲ 5.1×2 topics
- Cell Proliferation2▲ 73×2 topics
- Heart Failure2▲ 14×3 topics
- Immune Response2▲ 10×4 topics
- Immunotherapy2▲ 8.4×4 topics
- Breast Cancer2▲ 23×2 topics
- Obesity2▲ 7.4×4 topics
- PET Imaging2▲ 33×3 topics
- Pulmonary Hypertension2▲ 39×2 topics
- Treatment Guidelines2▲ 27×2 topics
- Cancer Therapy2▲ 9.2×3 topics
- Chronic Kidney Disease2▲ 22×1 topic
- Endothelial Dysfunction2▲ 23×2 topics
- Prostate Cancer2▲ 40×2 topics
- Right Heart Assessment2▲ 130×1 topic
- Imaging2▲ 20×3 topics
- Myocardial Infarction1▲ 19×3 topics
- Bisphosphonates1▲ 173×1 topic
- Dosimetry1▲ 59×2 topics
- Gene Therapy1▲ 21×4 topics
- Osteonecrosis of the Jaw1▲ 173×1 topic
- Tumor Regression1▲ 36×2 topics
- PET/CT1▲ 66×1 topic
- Radiopharmaceuticals1▲ 130×1 topic
- Targeted Therapy1▲ 16×1 topic
- Tumor Microenvironment1▲ 8.8×3 topics
- Tumor Suppression1▲ 50×2 topics
- tumor1▲ 66×1 topic
- Biomarkers1▲ 4.9×3 topics
- Metastatic Breast Cancer1▲ 58×2 topics
- Angiogenesis1▲ 9.8×4 topics
- Arginine Methylation1▲ 115×1 topic
- BRAF gene1▲ 193×1 topic
- Chamber Quantification1▲ 40×1 topic
- Diastolic Function1▲ 40×1 topic
- MAP Kinase1▲ 193×1 topic
- Protein Arginine Methyltransferases1▲ 115×1 topic
- Transcriptional Regulation1▲ 20×2 topics
Which research topics does Micropharma (Canada) publish most on?
By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Bone health and treatments, Radiopharmaceutical Chemistry and Applications and Medical Imaging Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 2 Bone health and treatments Oncology 1 works
- 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 4 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 5 Cancer-related gene regulation Molecular Biology 1 works
- 6 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
- 7 Melanoma and MAPK Pathways Molecular Biology 1 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 9 Cancer Research and Treatments Biotechnology 1 works
- 10 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Micropharma (Canada)'s research output changed?
Output in 2018–2022 was 12% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Montreal
- McGill University
- Université de Montréal
- Concordia University
- Université du Québec à Montréal
- Polytechnique Montréal
- McGill University Health Centre
- CAE (Canada)
- École de Technologie Supérieure
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.